Zydus announces EPICS-IIITM phase-II(b)/III adaptive pivotal clinical trial of Saroglitazar Mg in PBC Read more
US FDA approves Takeda’s Livtencity to treat people with post-transplant Cytomegalovirus infection Read more
Alembic Pharmaceuticals announces US FDA tentative approval for Dabigatran Etexilate capsules Read more
Alembic Pharmaceuticals announces US FDA final approval for formoterol fumarate inhalation solution Read more